CCADD, led by Professor Howard Lee, attended the 2026 Spring Conference of the Korean Society of Medical Informatics (KOSMI). The conference was held over three days, from June 24 to June 26, 2026, at OSCO in Cheongju and co-hosted by KOSMI and the Korea Health Industry Development Institute (KHIDI). This year’s theme was “From Operating System to Operating Society: Next Mission of Medical Informatics.” The sessions focused on artificial intelligence (AI) and large language models (LLMs) in medical informatics. Topics ranged from trustworthy medical AI to lifelog analysis and digital healthcare.

David Seung U Lee, a postdoctoral researcher at CCADD, gave an oral presentation in Session 2 (LLM-based Clinical Decision Support) on “DDI-Expert: Explainable Prediction of Pharmacokinetic Drug Interaction in Humans using Mixture of Experts.” His work moves beyond the limits of conventional drug–drug interaction (DDI) prediction. Using a Mixture of Experts (MoE) architecture that combines domain adaptation with domain application, it predicts pharmacokinetic DDI outcomes while also explaining their underlying mechanisms.

Yujin Kim, a student at CCADD, presented in the e-poster session (Generative AI and Clinical Text) on “Information Extraction and Structuring from Drug Approval Review Reports Using Large Language Models.” Her study introduced a pipeline that accurately extracts and structures information from drug approval review reports, which often have complex, multi-table layouts, while keeping costs low and performance high. The work covered the full process from model adaptation to evaluation.

Both presentations were well received at the conference. David Seung U Lee received the Best Oral Presentation Award, and Yujin Kim received the Best Poster Award. The awards mark another step in CCADD’s continued efforts to advance medical informatics through LLMs and AI-based approaches. CCADD will continue its research toward reliable and practical AI applications in healthcare and drug development.

A new research article, entitled “Assessing the representativeness of single-center EMR data on ten cancer types: A comparative analysis with national statistics from South Korea (2011–2021)”, authored by Won Jung-Hyun and Howard Lee, was published in the International Journal of Medical Informatics(IJMI). IJMI is a leading international journal that publishes high-impact research on the development, implementation, and real-world evaluation of health information systems and clinical informatics technologies.

This study evaluated whether single-center electronic medical record (EMR) data from Seoul National University Hospital (SNUH) could represent a real-world data source for oncology research in South Korea. To address this, the study analyzed annual incidence and prevalence patterns for ten major cancer types (e.g., breast, gallbladder/biliary tract, gastric, kidney, liver, lung, pancreatic, prostate, thyroid cancers, and leukemia) from 2011 to 2021 using national cancer statistics from the Korean Statistical Information Service (KOSIS) as reference. The study also examined age and gender distributions between two datasets. The results showed that the SNUH EMR data included 8.2% of national incident cancer cases and 10.7% of prevalent cases. The study also found no significant differences in age and gender distributions across all cancer types between the SNUH EMR and national data. In addition, strong correlations in annual trends were observed for several major cancers, including breast, lung, and pancreatic cancers. Overall, this study showed that single-center EMR data can be a valuable, representative clinical resource for oncology research in South Korea. At the same time, the study emphasizes that the underrepresentation of certain cancer types and external temporal factors, such as changes in clinical guidelines or major healthcare disruptions, should be carefully considered when generalizing findings from a single institution to broader populations.

CCADD members attended the 2026 Graduate School of Convergence Science and Technology Convergence Academic Festival, held on March 26, 2026, at the Faculty Hall of Seoul National University. This academic festival aimed to promote the exchange of research achievements among the Department of Applied Bioengineering, the Department of Molecular Medicine and Biopharmaceutical Sciences, and the Department of Health Science and Technology, while also providing a forum for presentation and discussion on bio-convergence research. The event brought together faculty members, researchers, and students from diverse fields to share recent research progress. The festival began with opening remarks delivered by Prof. Howard Lee, setting the stage for academic exchange among the participating departments.

More importantly, CCADD members presented one oral presentation and four poster presentations at the festival.

David gave an oral presentation titled “Mechanistic Reasoning Framework for Predicting Multi-Mechanism Pharmacokinetic Drug Interactions”. His work introduced a framework for predicting complex pharmacokinetic drug interactions involving multiple mechanisms.

Yujin’s poster “Annotation-Level Validation and Error Taxonomy for LLM-Assisted Korean–English Pharmaceutical Regulatory Corpus Construction”, focused on validation and error patterns in building a Korean–English pharmaceutical regulatory corpus using LLMs.

In a poster titled “LLM-Based Extraction of Adverse Drug Reactions from Real-World Clinical Notes”, Seoyoon presented an LLM-based approach for extracting adverse drug reaction information from real-world clinical notes.

Suhyun’s poster “Improving Causality Assessment of ADRs in Large Language Models through Rationale-Based Knowledge Distillation”, explored a method for improving the accuracy of causality assessment in LLMs through rationale-based knowledge distillation.

Seeun delivered a poster presentation titled “Generation of Multi-Lingual Synthetic Clinical Notes for Realistic Data Augmentation”, which proposed a framework for generating multilingual synthetic clinical notes to support realistic data augmentation.

Through this academic festival, CCADD members shared their recent research and exchanged ideas with researchers from related fields. The event provided an opportunity to present ongoing work, receive feedback, and engage in discussion on current topics in bio-convergence research.

On Friday, December 26, 2025, CCADD had the annual Year-End Workshop at Seoul National University, Seoul, South Korea. The workshop brought together all current CCADD members, part-time students and winter interns. Throughout a full day of presentations and discussions, CCADD members reflected on the year 2025 and looked ahead to 2026.

The workshop began with arrival and reception, followed by a series of presentations covering research progress, academic development, and practical lessons learned. As the first speaker, Seoyoon opened the program with a session titled “Looking Back on the Year 2025,” highlighting CCADD’s accomplishments in 2025 and celebrating the achievements of its members.

The yearly report was followed by Suhyun, who shared key takeaways from a year of full-time work at CCADD across two phases, from undergraduate research to the first semester of the master’s program. Then, Seeun presented “Preparation for the 1st Oral Presentation,” reflecting on her year-long research and walking through her conference-presentation preparation process. After that, Sunyoung delivered a presentation titled “Life in the Industry vs. Graduate School,” in which she introduced the role of a Clinical Project Leader at Daewoong Pharmaceutical Company highlighting key differences between life in industry and life as a master’s student. As the last session before lunch, David delivered a talk about the things he wished he had known early on, including having a daily habit of reading papers and making a usable personal template to take notes of what you learned from papers.

Following the morning sessions, participants took a break for lunch and then toured the main library at Seoul National University’s Gwanak Campus, exploring its study spaces, archives, and facilities. After the tour, members gathered for a photo time and captured group photos inspired by this year’s Pantone Color theme.

Soyoung presented “How I Learned Actually to Write” and explained what she learned while writing during the second half of 2025 under the supervision of Prof. Howard Lee. Then, Sungwook delivered a workshop talk titled “How I Became the Pre-crastinator at CCADD.” In the talk, he defined a “pre-crastinator” as someone who finishes tasks early and stays in the lab late to keep studying. It was followed by Chaeyoung, who shared her journey for the 2025 Google Solution Challenge, from ideation and development to presenting at the Asian Development Bank in the Philippines. She also reflected on pitching on an international stage and the lessons learned through receiving the award.

After a short break, the workshop continued with sessions focused on practical milestones and next-year planning. In the afternoon session, Seoyoon presented “First Grant Proposal: What I Learned and What I Wish I’d Known,” sharing key challenges and lessons from her first grant project management experience. In the tenth session, Yujin led “Looking Ahead to 2026 at CCADD,” presenting a vision for the center’s research trajectory in the coming year.  It also compiled target conferences for future submissions and concluded with a shared aspiration for deeper research in 2026.

Moreover, in the session, "AI 2027: Where we were, where we are, and where we will be", David went over the prospective report, "AI 2027," in which the authors made predictions on what will happen to the state of AI arms race between US and China. In addition to peeking into the future of AI, David emphasized the need for shifting gears toward using agentic AIs and understanding their inner workings by briefly discussing important developments in the field of agentic AI.

The most significant part of the workshop came in the closing talk, where Prof. Howard presented a paradigm shift from +AI to AI+. He contrasted a domain-first approach with an AI first approach and explaining how research strategy changes under an AI+ framework. He emphasized CCADD’s future direction toward AI-centered approach and proposed holding a “CCADD AI+ Conversion Meeting” in the early 2026 to brainstorm and define core research themes and strategies.

The workshop concluded with closing remarks from Prof. Howard, and everyone gathered for dinner. The 2025 CCADD Year-End Workshop provided members with an opportunity to exchange ideas, reflect on progress, and align on shared goals for the year ahead.

David Seung U Lee, a Ph.D. student at CCADD, and Seeun Park, an undergraduate researcher and the soon-to-be Master’s student at CCADD, received the Outstanding Presentation Awards at the 2025 Fall Conference of the Korean Society of Medical Informatics (KOSMI).

David presented his study titled "Improving Large Language Model-Based Drug-Drug Interaction Prediction Using Conformal Prediction." His research demonstrated that incorporating input features with coverage guarantees, verified through conformal prediction, significantly improves the performance of LLM-based DDI prediction in both in-context learning and fine-tuning settings.

Seeun Park, presented her study titled “Improving Synthetic Clinical Note Generation via Expert Prompting Reflecting Linguistic and Structural Characteristics.” Her research proposes a data augmentation framework that incorporates the knowledge of medical professionals into LLM-based prompting, coupled with a feedback-driven iterative generation loop. This approach enables the model to produce synthetic clinical notes that more closely reflect the characteristics of real-world clinical notes.

These awards highlight the growing importance of LLMs in the healthcare industry and recognizes the potential impact of our work in advancing AI-driven medical text generation.

CCADD members attended the 2025 Fall Conference of the Korean Society of Medical Informatics(KOSMI), held from November 23 to 24 at Songdo Convensia in Incheon. With the theme “Generative AI in Healthcare Systems: From Insight to Impact,” the conference showcased the latest developments, real-world applications, and future opportunities for generative AI in healthcare. Major sessions explored LLM evaluation, LLM-based clinical ation and validation, and AI-driven prediction of neurological disorders.

The conference featured keynote lectures from leading experts in Korea and Taiwan. Professor Sang-Hoon Jeon from Seoul National University Bundang Hospital discussed initiatives aimed at reducing global healthcare disparities, including the establishment of a Global Smart Hospital Network and the development of cloud-based platforms for clinician education and severe disease consultation. He emphasized that the key challenge is not merely how AI can reduce healthcare disparities, but how quickly high-quality medical services can reach those who are waiting for them. Professor Ming-Chin Lin from the College of Medicine at Taipei Medical University addressed the shared challenges facing both Korea and Taiwan—rapid population aging, declining birth rates, and increasing strain on healthcare professionals. He introduced Ambient Intelligence as the next evolution beyond ambient recording and traditional AI systems: a context-aware, ethically governed, sensor-integrated healthcare environment designed to support clinicians and empower patients.

More importantly, CCADD delivered five oral presentations.

David presented his work on “improving the performance of drug interaction prediction using conformal prediction”, which delved into a new method of selecting input for LLM-based prediction module using the statistical framework. 

Yujin presented her work on “Constructing a Domain-Specific Korean–English Parallel Corpus and Dictionary for Medical Translation Using a Large Language Model,” which aims to improve the reliability and consistency of LLM-based medical translation. By introducing a large-scale corpus construction framework, she provided foundational resources that can support future research in the field. During the session, she exchanged insights with reviewers and fellow researchers and explored ways to further expand and deepen the study.

Suhyun An presented her research on “Investigating LLM-based Reasoning and Training Strategies for automating causality assessment of adverse drug reactions”. Her study systematically explored optimal reasoning strategies and training methods to enable large language models to emulate the clinical decision-making process of medical experts.

Seoyoon Jang presented her work on "LLM-Based Extraction of Adverse Events from Real-World Clinical Notes", which leveraged open-source LLMs to build a privacy-preserving and robust framework capable of extracting adverse events from real-world clinical notes.

Seeun Park presented her work titled “Improving Synthetic Clinical Note Generation via Expert Prompting Reflecting Linguistic and Structural Characteristics”. Her research proposed a new synthetic data-augmentation framework that captures the characteristics of real-world clinical notes, demonstrating its potential to support large-scale, high-quality synthetic datasets for AI training.

Through this conference, CCADD members reaffirmed that their research aligns with the current interest in the generative AI, which will play a pivotal role in advancing the healthcare industry. The event strengthened our commitment to pursuing impactful research and contributing to the development of next-generation AI-driven healthcare systems.

Prof. Howard and his team (David and Yujin) presented their works at the 2025 American College of Clinical Pharmacology (ACCP) Annual Meeting, held in Phoenix, Arizona, from September 14–16, 2025. Under the theme “Leveraging Innovative Approaches to Transform Clinical Pharmacology,” the conference gathered experts to exchange insights on the evolving landscape in the field of clinical pharmacology.

The team delivered three poster presentations: 1) “Optimized In-Context Learning Outperforms Finetuning for Clinical Information Extraction across Diverse Healthcare Settings,” 2) “A Set of Inputs with Coverage Guarantee Enhances the Prediction of Drug Interactions,” and 3) “Constructing a Domain-Specific English–Korean Parallel Dictionary for Clinical Pharmacology and Regulatory Science Using a Large Language Model”. The presentations attracted considerable attention and prompted engaging exchanges among participants. The team’s research showed that in-context learning can serve as a data-efficient alternative to finetuning for clinical information extraction, offering practical guidance for applying large language models in healthcare settings with limited resources. They also demonstrated that incorporating input features with coverage guarantees, validated through conformal prediction, enhances the performance of LLM-based drug–drug interaction prediction. Lastly, the team showed that a domain-specific English–Korean parallel dictionary helps overcome language barriers and strengthens communication in clinical pharmacology and regulatory science.

As for the sessions in the ACCP conference, it began with a plenary session on optimizing patient outcomes through individualized pharmacotherapy. Subsequent symposia explored a wide range of critical topics, including diversity plans outlined by the U.S. Food and Drug Administration (FDA), therapeutic strategies for maternal and pediatric populations, innovations in dosing for preterm infants, therapeutic drug monitoring for biologics, and the application of artificial intelligence. Each meeting offered a clear picture of where clinical pharmacology is heading. The focus on individualized pharmacotherapy and model-informed drug development showed how artificial intelligence and mechanistic modeling are reshaping trial design and outcome prediction. At the same time, discussions on therapeutic drug monitoring for biologics and dosing in preterm infants revealed the field’s growing ability to tailor therapy for vulnerable populations.

Collectively, the conference underscored the expanding role of clinical pharmacology at the intersection of data science, patient diversity, and regulation. For the team, presenting at ACCP 2025 was not only an opportunity to share their own research but also a chance to situate their work within the broader trends shaping the field. The experience affirmed the value of their research trajectory and highlighted promising new directions for interdisciplinary and globally relevant contributions to clinical pharmacology.

CCADD members attended the 2025 Spring Conference of the Korean Society of Medical Informatics (KOSMI), held from June 22 to 24 at the Busan Port International Exhibition & Convention Center. Under the theme “AI and Human Collaboration in the Age of Generative AI,” the conference brought together experts from medicine, engineering, law, and industry to discuss the latest developments and practical applications in medical informatics.

Key topics included strategies to automate workflows involving electronic medical records (EMRs) , such as methods using large language models (LLMs), strategies for utilizing MyData in healthcare, integration of genomic and spatial biology data for precision medicine, the potential of quantum computing in medicine, and AI-driven clinical prediction and decision support systems (CDSS).

In the keynote speech, Prof. Adrian Zai of UMass Chan Medical School delivered a presentation titled “Steering the Future of Medicine: Human-Centered AI in the Generative Age.” He emphasized the importance of moving beyond what AI can do, toward how its impact should be directed in clinical settings. He highlighted human-centered design, ethical oversight, and global collaboration as essential to ensuring AI truly supports care delivery.

Dr. Yoona Choi, a former member of CCADD and now a research professor at Seoul National University Hospital's Child Cancer and Rare Disease Project, presented her work on developing an LLM-based computable phenotype for pediatric lymphoma subtypes. The model leverages structured and unstructured EMR data—such as pathology reports and genetic test results—to improve classification accuracy based on real-world clinical data.

Prof. Howard Lee, Founding Director of CCADD and CEO of the digital health startup PMATCH, introduced PillTalk, a mobile app that allows patients to independently check drug–drug interactions using public data made available by the Ministry of Food and Drug Safety. The app provides AI-powered, accessible information to help patients make safer medication decisions. Prof. Lee emphasized that public pharmaceutical datasets can be transformed into practical, patient-centered tools to enhance medication safety.

Through this conference, CCADD members were able to reflect on the essential role of interdisciplinary collaboration and responsible innovation in leveraging digital technologies to advance patient-centered care.

A research article, entitled “Country Contribution to Investigators of Pivotal Clinical Trials and their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012–2021”, authored by Yoona Choi, Jung-Hyun Won, Heeju Kim, YeSol Hong, Yujin Kim, and Howard Lee, has been published in Clinical Pharmacology & Therapeutics (CPT) on February 5, 2025. Clinical Pharmacology & Therapeutics (CPT) is one of the most prestigious journals in the field of clinical pharmacology (impact factor of 6.3 in 2023), reflecting its significant influence in translational medicine and regulatory science.

This study investigated the geographical distribution of investigators and authors in pivotal clinical trials (PCTs) for new drugs approved by the U.S. Food and Drug Administration (FDA) from 2012 to 2021 and its association with the racial and ethnic diversity of study participants. While PCTs are often conducted across multiple countries to ensure broad participant enrollment and generalizability of clinical trial findings, the diversity of trial participants remains inadequate, with a predominant representation of White. To address this, the study analyzed 429 new drugs, 734 PCTs, and 718 primary publications (PPubs), extracting data from FDA labels, review s, PPubs, and clinicaltrials.gov. The findings revealed that North America and Western Europe (NAWE) accounted for the largest proportion of PCT investigators (62.9%), PPub authors (81.7%), and lead authors (90.9%). Among 521 PPubs reporting racial and ethnic distribution of participants, the median Diversity Index (DI) was 0.33, with only 16.3% of PPubs exceeding a DI of 0.5.

This study shows that evidence generation for new drug approval has remained concentrated in NAWE, with an even stronger presence in PPub authorship. This study emphasizes that to improve the racial/ethnic diversity of PCT participants, investigators from non-NAWE countries should be encouraged to take on more leadership roles, thereby increasing their likelihood of serving as authors in PPub.

On Friday, December 27, 2024, the 2024 CCADD Year-End Workshop was successfully held at the Seoul National University (SNU) Yongon Campus. The event was attended by Prof. Howard Lee, CCADD members, interns, and alumni. Notably, Research Professor Yoona Choi joined the event in person, while Prof. Asa Johansson and Dr. Tae Kyu Chung participated online, adding an international dimension to the program.

The workshop began with a brief icebreaking session, followed by a series of meaningful presentations. The first presenter, Yunjin Choi, shared her growth and learning experiences over the past six months in her presentation titled “The Serendipitous Road: Lessons from the Past 6 Months.” Next, Yujin Kim reflected on her first year as a graduate student, highlighting her research projects, achievements, and key takeaways. In the afternoon session, Junghyun Won provided a retrospective on her 4.5 years as a graduate student, offering valuable insights into the diverse experiences of graduate life.

The main session reviewed CCADD's accomplishments in 2024, celebrating the research group's growth and achievements. Prof. Howard Lee commended the group’s continued success in research and publications. The workshop then shifted its focus to 2025, with a session outlining a roadmap emphasizing emerging AI concepts and innovative research ideas aligned with the latest trends.

Three special lectures added depth and inspiration to the workshop. Dr. Tae Kyu Chung, a postdoctoral researcher at the University of California San Francisco, delivered a lecture titled “Postdoc Diaries: A Glimpse of Life in the US,” offering a vivid account of his life and research abroad, which resonated strongly with the audience. Research Professor Yoona Choi reflected on her year as a research professor at Child Cancer and Rare Disease Project, Seoul National University Hospital. Her presentation detailed the challenges and achievements of her rigorous research journey, offering valuable insights for fellow researchers. Prof. Asa Johansson from Uppsala University delivered a lecture titled “Pharmacoepidemiology in the Era of Precision Health,” introducing the latest developments in precision medicine and pharmacoepidemiology. Her session provided an opportunity for attendees to exchange ideas with an international expert.

The workshop concluded with an inspiring speech by Prof. Howard Lee, who has been serving as the Dean of the Graduate School of Convergence Science and Technology at SNU. Prof. Lee praised CCADD's remarkable achievements throughout 2024 and expressed his strong support for the group’s ambitious goals in 2025. The 2024 CCADD Year-End Workshop provided members and alumni with a valuable opportunity to strengthen their relationships, exchange ideas, and align on a shared vision for the journey ahead.

The semester-long course "Understanding New Health Technology Development" successfully concluded on December 9 with final presentations by students. The event provided an opportunity for participants to demonstrate their comprehensive understanding of the drug development process and gain practical experience with its complexities.

During the presentations, students analyzed and presented the development journey of globally recognized drugs, including Leqembi, Wegovy, and Zolgensma. Each team focused on the New Drug Application (NDA) process, addressing preclinical and clinical phases, regulatory hurdles, and market entry strategies. Their presentations showcased a well-rounded understanding of the scientific, regulatory, and market challenges involved in drug development.

The course was designed to emphasize the importance of interdisciplinary collaboration in creating new health technologies. Students explored critical decision-making principles at each stage of the development process, equipping themselves with practical knowledge essential for careers in the health tech sector. Key topics in the presentations included — The mechanism of action and scientific foundations of the drugs, Preclinical and clinical testing phases, Regulatory approval procedures, and Market strategies and societal impact.

One student shared, "This course gave us the unique opportunity to design and analyze the entire drug development process, offering invaluable insights that extend beyond theoretical knowledge." The "Understanding New Health Technology Development" course concluded successfully, marking a significant milestone in fostering future professionals equipped to advance the health technology field.